INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/19/2026
Back to search
Official data from USPTO
MBIOVASC-TERM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MBIOVASC-TERM
ST13
US500000079207492Class
5, 9, 10, 42, 44
Filing
79207492
Registration
5455661
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
02/20/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
03/16/2017
Registration date
05/01/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/15/2024
Last transaction
02/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
80686 München, DE
Examiner
PINO, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Patente und Lizenzen
Representatives
P. JAY HINES MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for medical purposes namelyfor tissue engineering and regenerative medicine; pharmaceutical and veterinary preparations tissue engineering and regenerative medicine; medical preparations for tissue regeneration; sanitary preparations for medical purposes; dietetic foods for medical use; food for babies; medical plastersmaterials for dressingswaddingsgauzepledgets ; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological preparations for medical purposes for tissue regeneration; biological preparations for veterinary purposes for tissue regeneration; surgical implants comprised of living tissues; biological implantsa vital processed human or animal connective tissue
Class 9
Bioreactors for cell culturing; bioreactors for research usebioreactors for laboratory use
Class 10
Medical apparatus and instruments for use in surgery; medical apparatus and instruments for use in tissue engineering and regenerationdental and veterinary apparatus and instruments for use in tissue engineering and regeneration; artificial limbseyes and teeth; orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials; electrodes for medical use; testing apparatus for medical purposestissue testing apparatus; diagnostic apparatus for medical purposesdiagnostic apparatus for use in tissue engineering and regeneration; clothing for medical usefor orthopaedic or phlebology purposeselastic stockingselastic hose supportersknee high hosierythigh high hosierysupport bandages and belts for medical purposes; bonejointhipbreast prostheses; implants consisting of artificial materials; artificial organsimplant consisting of artificial materials
Class 42
Scientific and technological services and research and design relating theretoscientific researchtissue engineering and regeneration; scientific and industrial research in the field of tissue engineering and regenerative medicine; industrial analysis and research servicesindustrial research in the field of tissue engineering and regenerative medicine; scientific testing services in the field of tissue engineering and regenerative medicine; scientific consultancy in the field of tissue engineering and regenerative medicine; surveying; technical and scientific project planning for testing services in the field of tissue engineering and regenerative medicine; measurement servicesmeasurement evaluations in the field of tissue engineering and regenerative medicine; development of measuring and testing methods in the field of tissue engineering and regenerative medicine; material testing; quality control for others; research and development relating to new products for others; architectural consultation; construction drafting; technical research in the field of tissue engineering and regenerative medicine; mechanical research in the field of tissue engineering and regenerative medicine; physics research; chemical research; engineering; chemistry servicesresearch in the field of chemistry; computer programming services; services of a technical measurement and testing laboratorymaterial testing; chemical analysis; technical measuring servicesmeasurement evaluations in the field of tissue engineering and regenerative medicine; technological analysis services in the field of tissue engineering and regenerative medicine; architectural services; design and development of computer hardware and software; computer software installation and maintenance; computer website design services; research in the field of science and research conducted using data bases and the internetscientific research; medical research laboratory servicesmedical research
Class 44
Medical services; veterinary services; medical screening; hygienic and beauty care for human beings or animals; horticulture services
Publications
History of USPTO decisions and trademark events.
33 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/03/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
01/03/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/15/2025
C71T
CANCELLED SECTION 71
11/15/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/01/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/02/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/09/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
08/09/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/01/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/13/2018
PUBO
PUBLISHED FOR OPPOSITION
02/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/24/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
01/10/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/10/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
01/10/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2017
ALIE
ASSIGNED TO LIE
12/03/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2017
RFNT
REFUSAL PROCESSED BY IB
07/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/19/2017
RFRR
REFUSAL PROCESSED BY MPU
06/19/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/13/2017
CNRT
NON-FINAL ACTION WRITTEN
06/12/2017
DOCK
ASSIGNED TO EXAMINER
06/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/11/2017
Continuous trademark protection
Get notified about every new filing that threatens MBIOVASC-TERM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.